Cellular Research Introduces Whole Transcriptome Single Cell Precise Assays
July 29 2015 - 7:30AM
Business Wire
Cellular Research, Inc., today announced an early access program
for its new Whole Transcriptome Single Cell Precise™ Assays, which
enable absolute and direct molecular counting of the entire
transcriptome from single cells without any specialized equipment
or training.
“Recent technological advances have enabled the analysis of gene
expression at the single cell level,” according to John Ngai, the
Coates Family Professor of Neuroscience and Director of the QB3
Functional Genomics Laboratory at the University of California,
Berkeley. “These capabilities allow researchers to probe the
complexity of biological systems at unprecedented levels of detail
and have broad applications in the biological and biomedical
sciences.”
Whole Transcriptome Single Cell Precise Assays are unique
because they are the first commercial RNA-seq assay to enable
1,000s of cells to be sequenced per run and at a cost far lower
than existing alternatives. In addition, no expensive dedicated
laboratory equipment is needed to run the assays, and the
sequencing library is compatible with any Illumina sequencer.
“Precise assays enable users to see the true heterogeneity
within their samples by directly counting the number of each
transcript expressed by each individual cell,” said Martin
Pieprzyk, Director of Strategic Marketing for Cellular Research.
“Researchers can first use our Whole Transcriptome Precise Assays
as a discovery tool, and then transition to our Targeted Single
Cell or Targeted mRNA Precise Assays to validate specific genes and
pathways of interest at the highest throughput and lowest cost
possible.”
Based on Cellular Research’s patented Molecular Indexing™
technology, the Precise assays offer absolute quantization and
bias-free expression information. The assays allow the examination
of large numbers of standard or low-input mRNA samples from
precious samples, or whenever absolute quantitation is required.
The Precise assays combine molecular and sample indexing in 96- and
384-sample formats, enabling customers to sequence up to 4,608
samples on one sequencing run without investment in new equipment
or extensive training.
About Cellular Research
Cellular Research, Inc. is a biotechnology research and
development company founded by innovators from Silicon Valley and
Stanford University. Our mission is to develop and commercialize a
new generation of highly sensitive life science technologies and
products. In addition to introducing a portfolio of research
products, the Company has an active partnership program with
pharmaceutical and diagnostics companies advancing clinical
applications. For more information, please
visit http://www.cellular-research.com/ and follow us on
Twitter @Cell_Research.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150729005450/en/
Bioscribe, Inc., for Cellular ResearchNicole Litchfield,
415-793-6468Nicole@bioscribe.com